Patient-Reported Outcome Measures Used in Routine Care Predict for Survival at Disease Progression in Patients With Advanced Lung Cancer - Clinical Lung Cancer
Figure 3-2, Outcome Measures Framework - Tools and Technologies for Registry Interoperability, Registries for Evaluating Patient Outcomes: A User's Guide, 3rd Edition, Addendum 2 - NCBI Bookshelf
Secondary outcome measure. The median follow-up of 15.7 months. The... | Download Scientific Diagram
Overall Survival Results with KISQALI® (ribociclib)
Prioritizing Patient Preferences for Ovarian Cancer Treatment | Duke Health Referring Physicians
A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer - eClinicalMedicine
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health
Patient-Reported Outcome Measures Used in Routine Care Predict for Survival at Disease Progression in Patients With Advanced Lung Cancer - Clinical Lung Cancer
Evaluating eligibility criteria of oncology trials using real-world data and AI | Nature
Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer | NEJM
Trial Outcome Measures | Download Table
Trial Outcome Measures | Download Table
LENVIMA® (lenvatinib) HCP Website | Clinical Study Design
JCI Insight - A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia
Summary of the clinical trials and outcome measures for combination... | Download Table
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis | Prostate Cancer and Prostatic Diseases
Drug Trials Snapshot: LONSURF | FDA
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC | NEJM
Survival (time to event) Outcomes | Health Knowledge
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Articles Archives - Page 2 of 10 - GNS
A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer - eClinicalMedicine
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM
